If that 2019 article were to be updated, it would probably conclude that now RAC is the world's leading epitranscriptome company. For erasers, that's indisputable.
Accent and Storm are concentrating on writers, and they don't have any announced candidate drugs.
Gotham hasn't progressed on anything. It seems to be just a one-man company.
Dr Dominissini is well known in epitranscriptome circles and has no commercial conflict of interest, so he's the right man for our job.
Ann: Race-Chaim Sheba FTO Biomarker Collaboration, page-103
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.54 |
Change
-0.050(3.14%) |
Mkt cap ! $265.8M | |||
| Open | High | Low | Value | Volume |
| $1.59 | $1.59 | $1.53 | $75.78K | 48.69K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3339 | $1.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.55 | 2908 | 2 |
View Market Depth
| Last trade - 15.36pm 16/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |